🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, Erlotinib and 5-Fluorouracil (5-FU), Leucovorin and Oxalipla...
Status
Completed
Location
Translational Oncology Research International (TORI) Network
Start Date
2007-12
Trial ID
NCT00591123
The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-10-16
Trial ID
NCT06625320
The purpose of the study is to determine the feasibility of using magnetic ...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2021-12-23
Trial ID
NCT05108428
Treatments Being Tested
GastroPET is a prospective, multicenter, non-randomized interventional stud...
Status
Completed
Location
Masaryk Memorial Cancer Institute
Start Date
2018-08-01
Trial ID
NCT07791329
Treatments Being Tested
This study determined the maximum tolerated dose and safety of SU011248 (su...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00599924
Randomized, non-comparative, open-label, multi-centre Phase II study to eva...
Status
Recruiting
Location
Chu Dijon Bourgogne
Start Date
2024-02-16
Trial ID
NCT06278545
Treatments Being Tested
Patients with Her2 negative, previously untreated metastatic esophagogastri...
Status
Completed
Location
Klinikum St. Marien Amberg
Start Date
2018-11-07
Trial ID
NCT03647969
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as cetuximab and bevacizumab, can bl...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00571740
Treatments Being Tested
This is a phase 1b prospective, single arm, open-label trial determining th...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Center, University
Start Date
2025-06-27
Trial ID
NCT05733689
This was a randomized, placebo-controlled, double-blind study of vismodegib...
Status
Completed
Location
Multiple Locations
Start Date
2008-05
Trial ID
NCT00636610
Treatments Being Tested